- Delivering Pan India
Synagis® (Palivizumab) Palivizumab 50 mg / 0.5 mL vial by AstraZeneca. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Palivizumab 50 mg / 0.5 mL |
|---|---|
| Manufacturer | AstraZeneca |
| Country | Japan |
| Pack size | Palivizumab 50 mg / 0.5 mL: 1 vial |
| Storage | Store refrigerated at 2°C to 8°C. Do not freeze. |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Synagis® (Palivizumab) Palivizumab 50 mg / 0.5 mL Vial — Palivizumab Injection 50 mg/0.5 mL: A Sourcing Guide for Hospitals and Pharmacies
Synagis® is a palivizumab (humanised RSV monoclonal antibody) solution for intramuscular injection, supplied as a 50 mg/0.5 mL single-dose vial. The decision to prescribe palivizumab, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Synagis® (palivizumab) Palivizumab 50 mg / 0.5 mL vial to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the cancer medicines category. Supply is in bulk/wholesale quantities only.
Synagis (palivizumab) is a 50 mg/0.5 mL solution for intramuscular injection in a single-dose vial. The pack shown is a Spanish-language carton; third-party listings name AstraZeneca K.K. (Japan) as the trademark owner, and AstraZeneca Pharma India has been reported to hold import permission for palivizumab in India.
How it works, according to the label: Published literature describes palivizumab as a humanised monoclonal antibody directed against the respiratory syncytial virus (RSV) F protein. Indications, schedules and precautions are those in the pack insert.
The current US prescribing information for the manufacturer’s pack insert and published trial literature (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Synagis pack insert.
The IMpact-RSV trial of palivizumab in high-risk infants was published in Pediatrics (1998). Results and conclusions are those of the trial authors; A.K. Pharma does not interpret them.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Palivizumab 50 mg / 0.5 mL | Solution for intramuscular injection, single-dose vial | 1 vial |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
Hospitals, clinics and pharmacies in India that need to source this brand in bulk quantities from a licensed distributor.
Side effects and warnings are listed in the prescribing information or pack insert and are not summarised here; consult the treating physician.
All use should follow the approved prescribing information and the instructions of the treating physician.
Follow the storage instructions printed on the carton and in the pack insert.
Synagis is marketed by AstraZeneca. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Synagis through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Synagis available in India?
A.K. Pharma supplies Synagis (palivizumab) Palivizumab 50 mg / 0.5 mL vial to hospitals and pharmacies in India. Contact us for current availability.
What does Synagis contain?
Synagis is a palivizumab 50 mg/0.5 mL intramuscular injection in a single-dose vial; the pack shown is a Spanish-language carton.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Synagis be stored?
Palivizumab listings advise refrigeration at 2°C to 8°C without freezing; follow the carton and pack insert.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
